Keytruda (pembrolizumab)

pCPA File Number: 22757
Negotiation Status:
Concluded with an LOI
Indication(s):
Biliary tract carcinoma (BTC) in adult patients, locally advanced unresectable or metastatic, in combination with chemotherapy
Sponsor/Manufacturer:
Merck Canada Inc.
CDA-AMC Project Number:
PC0344-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: